Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome
نویسندگان
چکیده
منابع مشابه
Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine.
CONTEXT Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable b...
متن کاملPathogenic Factors in Postinfectious Irritable Bowel Syndrome - an Update
Teodora Iacob, Doina F. Țățulescu, Cristina Cijevschi Prelipcean, D. L. Dumitrașcu University of Medicine and Pharmacy ”Iuliu Hațieganu“-Cluj-Napoca Faculty of Medicine 1. Department of Infectious Diseases 3. Medical Department University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi Faculty of Medicine 3. Department of Medical Specialties (I) *Corresponding author. E-mail: ddumitrascu@umfclu...
متن کاملBiomarkers of Irritable Bowel Syndrome
Traditionally, irritable bowel syndrome (IBS) has not been regarded as an organic disease, and the pathophysiology of IBS is heterogeneous. Currently, the diagnosis of IBS is based upon the Rome diagnostic criteria. The performance of these criteria is only modest in predicting IBS, and moreover their validation is lacking. Additionally, as functional symptoms are common in the general populati...
متن کاملTherapy of the postinfectious irritable bowel syndrome: an update
After acute infectious gastroenteritis, up to thirty percent of patients present prolonged gastrointestinal symptoms and a part of those affected patients can have the diagnostic criteria for postinfectious irritable bowel syndrome. Treatment is symptom directed rather than curative and includes agents prescribed for the treatment of irritable bowel syndrome in general. Prophylaxis or early tre...
متن کاملPostinfectious Irritable Bowel Syndrome: Clinical Aspects, Pathophysiology, and Treatment
INTRODUCTION Bacterial diarrhea is considered a self-limiting illness lasting 3–5 days, but its complications can persist for weeks, months, and even years in some patients (1–3). One such complication is postinfectious irritable bowel syndrome (PI-IBS), defined as the development of new enteric symptoms meeting objective criteria of irritable bowel syndrome (IBS) in patients who had normal bow...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Travel Medicine
سال: 2015
ISSN: 1195-1982,1708-8305
DOI: 10.1111/jtm.12218